Related Experiment Videos
Scintigraphic imaging with 99mTc- exorphin C in rabbits
1Department of Nuclear Medicine, Medical School, Dokuz Eylül University, Inciralti, Turkey. turkan.ertay@deu.edu.tr
Summary
Technetium-99m-labeled exorphin C shows potential as an opioid receptor imaging agent. Studies in rabbits indicate high labeling efficiency and stability, with primary renal excretion.
Area of Science:
- Radiopharmaceutical Chemistry
- Nuclear Medicine
- Molecular Imaging
Background:
- Exorphin C is a peptide targeting opioid receptors in tissues and tumors.
- Radiolabeling Exorphin C with technetium-99m (99mTc) is a promising approach for imaging.
Purpose of the Study:
- To evaluate the radiopharmaceutical potential of 99mTc-labeled Exorphin C (99mTc-GE) for imaging opioid receptor-expressing tissues.
- To assess the stability and biodistribution of 99mTc-GE in a preclinical rabbit model.
Main Methods:
- Exorphin C was radiolabeled with 99mTc using glucoheptonate (GH) as a chelating agent.
- Quality control included ITLC, paper electrophoresis, and HPLC.
- Scintigraphic imaging was performed on rabbits, with and without receptor saturation.
Main Results:
- Labeling efficiency exceeded 98% with high stability (>5 hours).
- Significant brain uptake was observed, with reduced uptake after receptor saturation.
- Primary excretion route was renal, with minimal hepatobiliary excretion observed initially, which disappeared after receptor saturation.
Conclusions:
- 99mTc-GH-Exorphin C demonstrates good radiolabeling characteristics and stability.
- The compound shows potential for imaging opioid receptor-expressing tissues, particularly in the brain.
- Renal excretion is the predominant route, and receptor saturation influences biodistribution patterns.